Elobixibat is a pharmaceutical raw material that functions as an inhibitor of the ileal bile acid transporter (IBAT). It has been investigated in clinical trials for the management of chronic constipation and irritable bowel syndrome with constipation.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 439087-18-0
Tert-Butyl Elobixibat
pharmaceutical intermediate
2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetic acid
research compound
Odevixibat
ileal bile acid transporter inhibitor
Linerixibat
ileal bile acid transporter inhibitor
Lasmiditan
active pharmaceutical ingredient
Lasmiditan succinate
active pharmaceutical ingredient
Niflumic acid
active pharmaceutical ingredient
Eribulin mesylate
active pharmaceutical ingredient
2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid
XFLQIRAKKLNXRQ-UUWRZZSWSA-N
CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)N[C@H](C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC